ArticleImmunoTargets and therapy2025
Soluble Programmed Cell Death-1: A Potential Predictor of HBsAg Loss in Pediatric Patients with Chronic Hepatitis B Undergoing Peginterferon Therapy.
Guifeng Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.